Determination of the functionality of common APOA5 polymorphisms.
about
Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementApolipoprotein A5 and triglyceridemia. Focus on the effects of the common variantsThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchA single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou ChineseMultiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrationsIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS.Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) studyGene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndromeGenetic determinants of plasma triglyceridesTrans-ethnic fine-mapping of lipid loci identifies population-specific signals and allelic heterogeneity that increases the trait variance explained.Association of polymorphisms of genes involved in lipid metabolism with blood pressure and lipid values in mexican hypertensive individuals.Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndromeGenetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosisIncreased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.Clinical Utility of a Coronary Heart Disease Risk Prediction Gene Score in UK Healthy Middle Aged Men and in the Pakistani Population.Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 geneAPOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost TrialDeterminants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiencyIntracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segmentRare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy.An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site.Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.Apolipoprotein A-V association with intracellular lipid droplets.Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.The ins (cell) and outs (plasma) of apolipoprotein A-V.Genetic polymorphism in milk fat globule-EGF factor 8 (MFG-E8) is associated with systemic lupus erythematosus in human.Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.Identity-by-Descent Mapping Identifies Major Locus for Serum Triglycerides in Amerindians Largely Explained by an APOC3 Founder Mutation.Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.Apolipoprotein A5 3'-UTR variants and cardiometabolic traits in Koreans: results from the Korean genome and epidemiology study and the Korea National Health and Nutrition Examination Survey.Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change.APOA5 variants and metabolic syndrome in Caucasians.Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study.Sequence Analysis of APOA5 Among the Kuwaiti Population Identifies Association of rs2072560, rs2266788, and rs662799 With TG and VLDL Levels.Effects of APOA5 S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates.
P2860
Q26775009-AC44D678-F885-4DF4-A258-59096A280833Q28256394-36E2B129-421F-4F21-B801-ECBAF812D489Q28273374-684CB47A-0B36-4CAE-BCFD-9151004D82E2Q28275573-95CC37D1-AAD4-43E5-920B-2C8AE2561C1AQ28286033-61D7BDED-9495-427A-BD63-3640FCFBCB54Q28288723-2B3AB810-0EC6-4BA0-981E-C28CEBC8939FQ28294769-A599D896-3A28-4D5D-9CD3-0A8EAC186A7EQ31034509-7FD1DA4C-2061-4E60-AD7B-6BCCB174B9ECQ33954461-41565405-9CE2-4635-80D6-0F3CD3B50949Q34057144-DBFC1AAE-52AC-4C7A-AFC6-75A13622B804Q34503333-B063CA5D-5D00-46AB-B546-6D5895ABEDB0Q34649888-4B84DD68-CE66-49B6-B72F-9B8205DC3D54Q34815383-6E01674D-7560-4237-A575-85DDEAAE4FF5Q35532345-F4F1A1FC-4583-4D51-B120-C42B7EB2D257Q35575550-A87DE563-BFEA-42EB-9B62-26D89F216C53Q35592272-251A6FC1-17BF-4115-B19D-7DE53B4F3B83Q35680441-6A7A1ACB-D459-47B7-8831-C721DBC19A62Q35963956-FBB31C9F-D896-45A8-A7E7-F2F3D50CF8E6Q36231656-2AF47174-01A4-4589-9771-CD45A58E3E8DQ36496770-F457D63B-A66E-4627-93AF-DB3F87D475A9Q36558367-26967CCA-DD24-4E64-BF34-DEEAE8FED428Q36745069-A98A4BC7-35EB-4034-90BA-2762E5EC815EQ36920620-32AC744B-BB35-41EB-A59F-25420304D65CQ37441091-83D4D906-1C40-44FF-9C95-4DD16A28BB7DQ39303512-D0487C56-8CBF-4980-A9F2-BFEC778D1577Q39805075-10762FDD-D794-42E0-B33A-375951D1EDC4Q40140841-3AC3874C-6495-4748-84FA-CD3759BDDFB8Q40316899-CFC89118-F10E-442A-8040-B551B55C1C6AQ42119866-F7EF72C1-C3E1-407B-ACE5-FACB8FAD1348Q45837100-56A27029-9EAA-49AA-B979-2EA4544C9562Q46147591-12CCD3B7-4D4C-421C-8FD1-740353C96E19Q46754557-89F3B7D7-2600-48CA-B459-21E08D105E92Q48570311-3EC1B625-40A0-4160-8FD9-459747FB7996Q48897669-20B2A76E-5B76-4072-928C-DCE1E8128E89Q49216600-9EEBA1EF-1C1A-4860-899D-04F1D6626C76Q50701532-805E0CDC-F9AA-4448-B332-11A8142B303CQ51464229-459A12AF-8424-4DBD-B13C-59DE588596E8Q51503282-F4C8F315-57E7-4554-A3AC-774085C31D2EQ52568322-8F1B43CA-94B6-4091-BEF5-324D68B44D9AQ54377097-58447CA1-D228-480B-8073-14AA524E626C
P2860
Determination of the functionality of common APOA5 polymorphisms.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Determination of the functionality of common APOA5 polymorphisms.
@en
type
label
Determination of the functionality of common APOA5 polymorphisms.
@en
prefLabel
Determination of the functionality of common APOA5 polymorphisms.
@en
P2093
P2860
P356
P1476
Determination of the functionality of common APOA5 polymorphisms.
@en
P2093
Jutta Palmen
Steve E Humphries
Wendy Putt
P2860
P304
28215-28220
P356
10.1074/JBC.M502144200
P407
P577
2005-06-07T00:00:00Z